An FI constructed exclusively from routinely collected laboratory variables can measure frailty and predict adverse outcomes in SLE. It may serve as a convenient screening tool to detect subclinical frailty and promote early risk mitigation in this population.
Burns et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: